Google Review I cant say enough Tammy and Kelly are the best
Federal Drug Administration have received reports of adverse events, some including hospitalizations on compounded GLP-1 drugs due to dosing errors or incorrect doses with self-administration
5 Ingredion's VITESSENCE pea protein isolates and concentrates deliver protein in clean label formats that support satiety without compromising texture or taste critical factors for creating high-protein food and beverages that consumers will enjoy
Co., Ltd., n=60) [Weight Loss/Efficacy] Trials: NCT07677891 | Mechanism: GLP-1/GLP-2 dual agonist CLARA Trial Phase 2 investigating the biological impact of GLP-1/GIP receptor agonists in patients with breast cancer (Universitaire Ziekenhuizen KU Leuven, n=168) [New Indications] Trials: NCT07676331 (CLARA) | Mechanism: Dual GLP-1/GIP agonist Semaglutide microarray patch (VX-201) Phase 1 comparing epi-intradermal delivery to standard subcutaneous injection in healthy overweight and obese participants (Terrestrial Bio, n=62) [Novel Delivery] Trials: NCT07673900 | Mechanism: GLP-1 receptor agonist This newsletter compiles publicly available information from press releases, news sources, and trial registries
These agencies assessed the clinical trial data, ensuring the drugs safety, efficacy, and quality